AGO1 and obesity due to melanocortin 4 receptor deficiency: Hepatic Ago1 appears to be unnecessary for obesity-induced pathophysiology, as it has been reported that deletion of hepatic Ago1 had no significant effect on weight gain, glucose tolerance, or insulin sensitivity under obese conditions (27).